Author:
Yeboa Debra Nana,Rutter Charles E.,Park Henry S.,Lester-Coll Nataniel H.,Corso Christopher D.,Mancini Brandon R.,Bindra Ranjit S.,Contessa Joseph,Yu James B.
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference26 articles.
1. Radiation therapy with concomitant and adjuvant temozolomide or radiation therapy with adjuvant PCV or temozolomide alone in treating patients with anaplastic glioma (CODEL Trial). https://www.clinicaltrials.gov/ct2/show/NCT00887146?term=NCT00887146&rank=1: ClinicalTrials.gov; October 2009. p. Trial Identifier NCT00887146.
2. Radiation therapy with or without temozolomide in treating patients with anaplastic glioma (CATNON Trial). https://www.clinicaltrials.gov/ct2/show/NCT00626990?term=NCT00626990&rank=1: ClinicalTrials.gov; December 2007. p. Clinical Trials Identifier NCT00626990.
3. Van Den Bent MJ, Erridge S, Vogelbaum MA, Nowak AK, Sanson M, Brandes AA, et al. Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q co-deletion: An Intergroup trial. ASCO Meeting Abstracts; 2016; 34: LBA2000.
4. (NCDB) NCDB. NCDB Overview. American College of Surgeons; 20015.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献